bpc 157 hims & Hers shares are trading higher after an FDA advisory panel recommended adding BPC-157 to the 503A compounding list, potentially widening access through licensed pharmacies BPC-157 – Research Peptide |

BPC 157 Research Peptide American Peptides HIMS THE VOTE FOR BPC 157 HAPPENS AT 11:45 A.M. ET HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer Most FDA advisers say peptides like BPC 157 and TB 500 should be made available in the U.S. Here's what happens next. MarketWatch

SKU: 40363207221 · From eipa.cz